Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maria Cristina Vedovati
Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients With Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study
TH Open
Related publications
Optimal INR Level in Patients With Atrial Fibrillation With EHRA Type 2 Valvular Heart Disease Receiving Warfarin
Journal of Arrhythmia
Cardiovascular Medicine
Cardiology
Patients’ Priorities for Oral Anticoagulation Therapy in Non-Valvular Atrial Fibrillation: A Multi-Criteria Decision Analysis
American Journal of Cardiovascular Drugs
Medicine
Cardiovascular Medicine
Pharmacology
Cardiology
International Variation in Use of Oral Anticoagulation Among Heart Failure Patients With Atrial Fibrillation
American Heart Journal
Cardiovascular Medicine
Cardiology
Analysis of the microRNA Signature in Left Atrium From Patients With Valvular Heart Disease Reveals Their Implications in Atrial Fibrillation
PLoS ONE
Multidisciplinary
The Antithrombotic Therapy of Atrial Fibrillation in Patients With Coronary Heart Disease
Russian Open Medical Journal
Medicine
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients With ESRD: Verdict 2
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Atrial Fibrillation Onset Risk in Patients With Metabolic Syndrome: Prospective Study
Russian Journal of Cardiology
Cardiovascular Medicine
Cardiology
Under-Use of Warfarin for Patients With Non-Valvular Atrial Fibrillation in Japan
Internal Medicine
Internal Medicine
Medicine
Anticoagulation in Patients With Atrial Fibrillation. Underuse of Warfarin Is Multifactorial.
BMJ
